BiomX (PHGE) Change in Cash (2018 - 2026)
BiomX (PHGE) posted Change in Cash of -$3.8 million for Q1 2026, down 20.84% sequentially from -$3.1 million in Q4 2025, and down 216.45% YoY from $3.3 million in Q1 2025.
BiomX (PHGE) Change in Cash (2018 - 2026) Analysis & Trends
BiomX has reported Change in Cash for 9 years, with the latest figure at -$3.8 million in Q1 2026.
- Quarterly Change in Cash fell 216.45% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.1 million (up 12.16% YoY) and the FY2025 annual result came in at -$13.1 million, down 720.52% from the prior year.
- Change in Cash fell to -$3.8 million in Q1 2026 per PHGE's latest filing, from -$3.1 million in the prior quarter.
- Over five years, Change in Cash peaked at $3.3 million in Q1 2025 and troughed at -$17.3 million in Q1 2022.
- A 5-year average of -$5.6 million and a median of -$6.4 million in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2024: Change in Cash surged 105.65% in 2023, then sank 2932.34% in 2024.
- Over 5 years, Change in Cash stood at -$5.7 million in 2022, then slumped by 32.84% to -$7.6 million in 2023, then advanced by 11.67% to -$6.7 million in 2024, then surged by 53.14% to -$3.1 million in 2025, then retreated by 20.84% to -$3.8 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$3.8 million, -$3.1 million, and -$7.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | -3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.79 Mn |
| Dec 31, 2025 | -3.13 Mn |
| Sep 30, 2025 | -7.13 Mn |
| Jun 30, 2025 | -6.08 Mn |
| Mar 31, 2025 | 3.25 Mn |
| Dec 31, 2024 | -6.69 Mn |
| Sep 30, 2024 | -8.10 Mn |
| Jun 30, 2024 | -11.39 Mn |
| Dec 31, 2023 | -7.57 Mn |
| Sep 30, 2023 | -7.26 Mn |
| Jun 30, 2023 | 402,000.00 |
| Mar 31, 2023 | -2.01 Mn |
| Dec 31, 2022 | -5.70 Mn |
| Sep 30, 2022 | -741,000.00 |
| Jun 30, 2022 | -7.12 Mn |
| Mar 31, 2022 | -17.35 Mn |
| Dec 31, 2021 | -5.21 Mn |
| Sep 30, 2021 | 21.07 Mn |
| Jun 30, 2021 | 6.85 Mn |
| Mar 31, 2021 | 3.17 Mn |